Company
Neumirna Therapeutics
miRNA-based therapies for neurological diseases.
Also known as Neumirna Therapeutics ApS
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Copenhagen, Denmark
- Founded
- 2020
- Legal name
- Neumirna Therapeutics ApS
Claim, correct or request removal
Record updated 28 September 2026
About
We are committed to unlocking the full potential of miRNA therapy as a new frontier in the treatment of neurological diseases. With diligence and creativity, we advance promising therapies that harness the power of miRNA biology to effectively treat diseases such as Epilepsy and Parkinson’s.
Funding snapshot
- Total raised
- $250KSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Grant, $250K2025-06-11
Funding rounds
- Grant
- $250K2025-06-11, Company stated
- Series A
- 2025-01-08
- Grant
- 2024-02-29
Loading relationship preview